Oral anticoagulation and risk of bleeding in elderly patients - The aspect of polypharmacy;Blutungskomplikationen bei geriatrischen Patienten unter oraler Antikoagulation - Aspekte der Polypragmasie

Wiener Medizinische Wochenschrift

Volumn 160, Issue 11-12, 2010, Pages 270-275

  Roller, Regina E ^a   Iglseder, Bernhard ^b   Dovjak, Peter ^c   Lechleitner, Monika ^d   Sommeregger, Ulrike ^e   Benvenuti Falger, Ursula ^d   Otto, Ronald ^a   Böhmdorfer, Birgit ^e   Gosch, Markus ^d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c Abteilung fur Akutgeriatrie/Remobilisation   (Austria)

^d Hospital Hochzirl   (Austria)

^e Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel   (Austria)

Author keywords

Anticoagulant; Bleeding risk; Drug interaction; Elderly; Stratification model

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; CARBAMAZEPINE; CIPROFLOXACIN; CLARITHROMYCIN; CLOPIDOGREL; CYTOCHROME P450; ERYTHROMYCIN; FLUCONAZOLE; FLUINDOSTATIN; FLUVOXAMINE; GEMFIBROZIL; ISONIAZID; LEVOTHYROXINE; METRONIDAZOLE; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENPROCOUMON; PHENYLBUTAZONE; PHENYTOIN; PYRIMIDINE; RIFAMPICIN; SERTRALINE;

ALCOHOL ABUSE; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; DIABETES MELLITUS; DIGESTIVE SYSTEM ULCER; DRUG ABUSE; DRUG ELIMINATION; DRUG METABOLISM; GENDER; GERIATRIC DISORDER; HUMAN; INTERNATIONAL NORMALIZED RATIO; POLYPHARMACY; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

EID: 77957301150     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-010-0785-2     Document Type: Article

References (24)

1. G Palaretti J Hirsh C Legnani C Manotti A D'Angelo V Pengo M Moia G Guazzaloca S Musolesi S Coccheri 2000 Oral anticoagulation treatment in the elderly Arch Int Med 160 470 478 10.1001/archinte.160.4.470
2. SD Fihn CM Callhan DC Martin MB McDonell JG Heinikoff RH White 1996 The risk for severity of bleeding complications in elderly patients treated with warfarin Ann Intern Med 124 970 979 1:STN:280:DyaK283ht1egsA%3D%3D 8624064
3. FJM Van der Meer FR Rosendaal JP Vandenbroucke E Briet 1996 Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants Thromb Haemost 76 12 16 1:STN:280:DyaK28vhs1ensQ%3D%3D 8819244
4. MN Levine G Raskob S Landefeld C Kearon 2001 Hemorrhagic complications of anticoagulant treatment Chest 119 108S 121S 10.1378/chest.119.1-suppl.108S 1:STN:280:DC%2BD3M7ptlaksA%3D%3D 11157645
5. National Institute for Health and Clinical Excellence. Atrial fibrillation: National Clinical Guideline for management in primary and secondary care. London, National Institute for Health and Clinical Excellence, 2006
6. V Fuster LE Rydén RW Asinger DS Cannom HJ Crijns RL Frye JL Halperin GN Kay WW Klein S Lévy RL McNamara EN Prystowsky LS Wann DG Wyse RJ Gibbons EM Antman JS Alpert DP Faxon V Fuster G Gregoratos LF Hiratzka AK Jacobs RO Russell SC Smith WW Klein A Alonso-Garcia C Blomström-Lundqvist G De Backer M Flather J Hradec A Oto A Parkhomenko S Silber A Torbicki 2001 American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association/Tasc Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology J Am Coll Cardiol 38 1231 1266 10.1016/S0735-1097(01)01587-X 1:STN:280:DC%2BD3Mrjs1WlsA%3D%3D 11583910
7. EM Hylek 2001 Oral anticoagulants. Pharmacologic issues for the use in the elderly Clin Geriatr Med 17 1 13 10.1016/S0749-0690(05)70102-6 1:STN:280:DC%2BD3M7nt1aluw%3D%3D 11270124
8. RI Shorr WA Ray JR Daugherty MR Griffin 1993 Concurrent use of non-steroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease Arch Intern Med 153 1665 1670 10.1001/archinte.153.14.1665 1:STN:280:DyaK3szis1SltA%3D%3D 8333804 (Pubitemid 23217872)
9. L Laine R Smith K Min C Chen RW Dubois 2006 Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs Aliment Pharmacol Ther 24 751 767 10.1111/j.1365-2036.2006.03043.x 1:CAS:528:DC%2BD28XhtFGqsrvE 16918879
10. E Hylek 2001 Oral anticoagulants. Pharmacologic issues for use in the elderly Clin Geriatr Med 17 1 13 10.1016/S0749-0690(05)70102-6 1:STN:280:DC%2BD3M7nt1aluw%3D%3D 11270124
11. DJ Greenblatt LL von Moltke 2005 Interaction of warfarin with drugs, natural substances and foods J Clin Pharmacol 45 127 132 10.1177/ 0091270004271404 1:CAS:528:DC%2BD2MXksFyhtrk%3D 15647404 (Pubitemid 40490435)
12. MC Fang RS Stafford JN Ruskin DE Singer 2004 National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation Arch Intern Med 164 55 60 10.1001/archinte.164.1.55 14718322 (Pubitemid 38081240)
13. National Collaborating Center for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London, UK: Royal College of Physicians, 2006
14. RJ Beyth LM Quinn CS Landefeld 1998 Prospective evaluation of an index predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 91 99 10.1016/S0002-9343(98)00198-3 1:CAS:528:DyaK1cXlvVamsr4%3D 9727814 (Pubitemid 28405230)
15. SL Aspinal BE DeSanzo LE Trilli CB Good 2005 Bleeding risk index in an anticoagulation clinic: assessment by indication and implications for care J Gen Intern Med 20 1008 1013 10.1111/j.1525-1497.2005.0229.x (Pubitemid 41726654)
16. PS Wells MA Forgie M Simms A Green D Touchie G Lewis J Anderson MA Rodger 2003 The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep vein thrombosis and pulmonary embolism Arch Intern Med 163 917 920 10.1001/archinte.163.8.917 12719200 (Pubitemid 36519737)
17. PMM Kuijer BA Hutten MH Prins HR Büller 1999 Prediction of the risk of bleeding during anticoagulation treatment for venous thromboembolism Arch Intern Med 159 457 460 10.1001/archinte.159.5.457 1:STN:280:DyaK1M7ntlanug%3D%3D 10074953 (Pubitemid 29108910)
18. T Shireman JD Mahnken PA Howard TF Kresowik Q Hou EF Ellerbeck 2006 Development of a contemporary bleeding risk model for elderly warfarin recipients Chest 130 1390 1396 10.1378/chest.130.5.1390 17099015 (Pubitemid 44786731)
19. P Peterson M Grind J Adler 2003 Ximelagatran versus warfarin for stroke prevention for patients with nonvalvular atrial fibrillation: SPORTIF II. A dose guiding tolerability and safety study J Am Coll Cardiol 41 1451 1455
20. M Jones P McEwan CL Morgan JR Peters J Googfellow CJ Currie 2005 Evaluation of the pattern of treatment, level of anticoagulation control and outcome of treatment with warfarin in patients with non-valvular atrial fibrillation: a record linkage study in a large British population Heart 91 472 477 10.1136/hrt.2004.042465 1:CAS:528:DC%2BD2MXjtlartrs%3D 15772203 (Pubitemid 40432773)
21. C Van Walraven N Oake P Wells AJ Forster 2007 Burden of potentially avoidable anticoagulant associated hemorrhagic and thromboembolic events in the elderly Chest 131 1508 1515 10.1378/chest.06-2628 17317732 (Pubitemid 46762360)
22. C Heneghan P Alonso-Coello JM Garcia-Alamino R Perera E Meats P Glasziou 2006 Selfmonitoring of oral anticoagulation: a systematic review and meta-analysis Lancet 367 404 411 10.1016/S0140-6736(06)68139-7 1:STN:280:DC%2BD28%2FntlSguw%3D%3D 16458764 (Pubitemid 43184260)
23. N Kagansky H Knobler E Rimon Z Ozer S Levy 2004 Safety of anticoagulation therapy in well-informed older people Arch Intern Med 164 2044 2049 10.1001/archinte.164.18.2044 15477441 (Pubitemid 39390563)
24. AGS Clinical Practices Committee American Geriatric Society 2000 The use of oral anticoagulants (warfarin) in older people J Am Geriatr Soc 48 224 227